Can a Mega-Dose of water pills help heart failure patients?
NCT ID NCT06036914
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a very high dose of the diuretic bumetanide can remove more fluid than standard doses of furosemide in people hospitalized with worsening heart failure. Twenty patients received either the ultra-high dose or the usual dose over 24 hours. The goal was to see if the stronger dose safely increases urine output and improves symptoms like swelling and shortness of breath.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bumetanide (ultra-high dose diuretic) and Furosemide (standard dose diuretic)
What this could lead to
If it works, this could point toward a more effective way to quickly remove excess fluid in heart failure patients, potentially reducing hospital stay and symptoms.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. High-dose diuretics can also cause kidney problems or electrolyte imbalances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States